[Kaposi's sarcoma of the laryngopharynx].
Zenger
V G
VG
Synebogov
S V
SV
Kadyrova
E V
EV
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007822:Laryngeal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D007830:Larynx / Q000473:pathology; D010610:Pharyngeal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D010614:Pharynx / Q000473:pathology; D011447:Prospidium / Q000008:administration & dosage / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D013997:Time Factors
D000970:Antineoplastic Agents; D011447:Prospidium